Stocks Crossing 50-Day SMA 11/14: (FB) (FRO) (SPLS) Above; (CIM) (BAC) (NOK) Below
- Market Wrap: Stocks Cry for Argentina; Tesla's 'Electrified' Q2 Report, Outlook; T-Mobile Gets New Suitor
- Tesla Motors, Inc. (TSLA) Tops Q2 EPS by 7c
- LinkedIn (LNKD) Tops Q2 EPS by 12c; Guides Above the Street
- Stocks Sink on Argentine Default and Rate Hike Worries
- Iliad Offered $33 Per Share for T-Mobile (TMUS)
Crossing and above:
Crossing and below:
- Facebook (Nasdaq: FB) - up 11.5 percent. Shrugging off a massive lock-up expiration today as investors continue to see better things for the social networking giant in the future. Click here for a little more confidence.
- Frontline (NYSE: FRO) - up 18.6 percent. Moving higher amid Overseas Shipholding (NYSE: OSG) filing for bankruptcy, as at least one firm sees VLCC rates moving higher. For more color, click here.
- Staples, Inc. (Nasdaq: SPLS) - up 2.2 percent. Beat Q3 EPS expectations by 1 cent, though revs of $6.35 billion were a little light..
Crossing and below:
- Chimera Investment (NYSE: CIM) - down 5.6 percent. Said it would be filing its 10-Q late. For more color, click here.
- Bank of America Corp. (NYSE: BAC) - down 3.9 percent. BofA on a three-session slide amid commencing a tender offer for MBIA (NYSE: MBI) debt on Tuesday. Overall, financials are mixed on the session.
- Nokia (NYSE: NOK) - down 1.1 percent. Seeing a little pressure following new data out of Gartner that the mobile phone giant slipped to 7th place from 3rd in terms of total smartphone sales. For more, click here.
You May Also Be Interested In
- Tekmira Pharmaceuticals (TKMR) Stock Quietly Gains Steam on Ebola Outbreak
- UPDATE: Impax Laboratories (IPXL) Issued Form 483 Following FDA Inspection of Taiwan Facility
- EDAP TMS S.A. (EDAP) trading halted with news pending
Create E-mail Alert Related CategoriesSpecial Reports, Technicals, Trader Talk
Related EntitiesBank of America, Bankruptcy, Stocks crossing the 50-day simple moving average
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!